Arcus Biosciences Inc
RCUS
Market Cap$1.59B
Close$
$20.04
18.6% upside
Current Fair Value
18.6% upsideUndervalued by 18.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.59 Billion |
|---|---|
| Enterprise Value | $593.04 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.99 |
| Beta | 1.62 |
| Outstanding Shares | 90,953,011 |
| Avg 30 Day Volume | 602,977 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.87 |
|---|---|
| PEG | 7.24 |
| Price to Sales | 8.45 |
| Price to Book Ratio | 2.41 |
| Enterprise Value to Revenue | 2.5 |
| Enterprise Value to EBIT | -2.37 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data